Bliss GVS Pharma Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
16
Price Target
Rp0.00
Consensus
-
Upside
31.58%
Analysts
0
Stock Rating
16
Upside
31.58%
Analysts
0
Price Target
Rp0.00
-

Bliss GVS Pharma Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Bliss GVS Pharma's Price has decreased from Rp203.59 to Rp0.00 – a 100.00% drop! In the next year, analysts believe that Fair Value will reach Rp0.00 – an increase of 100.00%. For the next five years, experts predict that Bliss GVS Pharma's Fair Value will grow at a rate of 100.00%.

2026 Fair Value Forecast
Rp0.00
2027 Fair Value Forecast
Rp0.00
2028 Fair Value Forecast
Rp0.00
2029 Fair Value Forecast
Rp0.00
2030 Fair Value Forecast
Rp0.00

Bliss GVS Pharma Revenue Forecast for 2023 - 2025 - 2030

Bliss GVS Pharma's Revenue has grown In the last three years, rising from Rp6.89B to Rp7.52B – a growth of 9.03%. The next year, 0 experts forecast that Bliss GVS Pharma's Revenue will decrease by 1.30%, reaching Rp7.42B. In 2030, professionals predict that Bliss GVS Pharma's Revenue will decrease by 5.18%, reaching Rp7.13B.

2024 Rev Forecast
Rp7.42B
2025 Rev Forecast
Rp6.87B
2026 Rev Forecast
Rp7.07B
2027 Rev Forecast
Rp7.22B
2028 Rev Forecast
Rp7.30B
2029 Rev Forecast
Rp7.15B
2030 Rev Forecast
Rp7.13B

Bliss GVS Pharma Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Bliss GVS Pharma has seen a decline in its Dividend per Share, from Rp0.50 to Rp0.50 – a 0.00% decrease. According to the 0 analysts polled, in the next year, Bliss GVS Pharma's Dividend per Share will fall by 0.00%, reaching Rp0.50. By 2030, professionals believe that Bliss GVS Pharma's Dividend per Share will have decreased by 0.00%, falling to Rp0.50.

2024 DPS Forecast
Rp0.50
2025 DPS Forecast
Rp0.50
2026 DPS Forecast
Rp0.50
2027 DPS Forecast
Rp0.50
2028 DPS Forecast
Rp0.50
2029 DPS Forecast
Rp0.50
2030 DPS Forecast
Rp0.50

Bliss GVS Pharma Free Cash Flow Forecast for 2023 - 2025 - 2030

Bliss GVS Pharma EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Bliss GVS Pharma's EBITDA has fallen from Rp1.21B to Rp1.16B – a 4.28% decrease. In the next year, analysts predict that EBITDA will jump to Rp1.18B – up 2.06% from the current level. By 2030, professionals believe that Bliss GVS Pharma's EBITDA will decrease by 0.78%, reaching Rp1.15B – a concerning trend for the company.

2024 EBITDA Forecast
Rp1.18B
2025 EBITDA Forecast
Rp1.14B
2026 EBITDA Forecast
Rp1.15B
2027 EBITDA Forecast
Rp1.15B
2028 EBITDA Forecast
Rp1.16B
2029 EBITDA Forecast
Rp1.15B
2030 EBITDA Forecast
Rp1.15B

Bliss GVS Pharma EBIT Forecast for 2023 - 2025 - 2030

Bliss GVS Pharma's EBIT has decreased In the last three years, from Rp1.11B to Rp986.49M – a 11.17% drop. Analysts predict that Bliss GVS Pharma's EBIT will increase in the upcoming year, reaching Rp1.04B. This would represent an increase of 5.04%. Over the next seven years, experts predict that Bliss GVS Pharma's EBIT will grow at a rate of 1.40%.

2024 EBIT Forecast
Rp1.04B
2025 EBIT Forecast
Rp0.99B
2026 EBIT Forecast
Rp1.00B
2027 EBIT Forecast
Rp0.99B
2028 EBIT Forecast
Rp1.01B
2029 EBIT Forecast
Rp1.00B
2030 EBIT Forecast
Rp1.00B

Bliss GVS Pharma EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Bliss GVS Pharma's EPS has decreased from Rp11.99 to Rp0.00 – a 100.00% drop! In the next year, analysts believe that EPS will reach Rp0.00 – an increase of 100.00%. For the next five years, experts predict that Bliss GVS Pharma's EPS will grow at a rate of 100.00%.

2026 EPS Forecast
Rp0.00
2027 EPS Forecast
Rp0.00
2028 EPS Forecast
Rp0.00
2029 EPS Forecast
Rp0.00
2030 EPS Forecast
Rp0.00